{
  "ticker": "ADO",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02958684",
  "id": "02958684",
  "pages": 4,
  "price_sensitive": false,
  "date": "20250616",
  "time": "0951",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250616/pdf/06ks7hklblg943.pdf",
  "summary": "**Material Information Summary:**  \n\n- **Commercial Evaluation Agreement**: AnteoTech\u2019s Ultranode\u2122 silicon anode technology to be trialled by Wyon AG for potential integration into medical device batteries (e.g., cochlear implants).  \n- **Key Benefit**: Ultranode\u2122 may deliver **~30% higher energy capacity** vs. graphite batteries, with **6-month evaluation timeline**.  \n- **Commercial Potential**: Successful evaluation could lead to licensing and supply agreements, marking AnteoTech\u2019s entry into the medical battery market.  \n- **No Immediate Financial Impact**: No revenue or capital adjustment disclosed.  \n\n**Omitted**: Background details, management quotes, historical agreements, non-material operational updates.",
  "usage": {
    "prompt_tokens": 2593,
    "completion_tokens": 145,
    "total_tokens": 2738,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-15T23:57:07.735659"
}